

Is Ibrexafungerp (Brexafemme) in shortage in 2026? Get the latest update on availability, cost, and what you can do if you can't find it.
If you've been prescribed Ibrexafungerp — sold as Brexafemme — and had trouble filling your prescription, you're probably wondering: is there an actual shortage, or is something else going on?
The short answer is that Ibrexafungerp is not currently listed on the FDA's official drug shortage database. But that doesn't mean it's easy to find. As a single-source brand-name drug made by one company (Scynexis, Inc.), Brexafemme has limited distribution that can make it feel like it's in shortage — even when it technically isn't.
Here's everything you need to know about Ibrexafungerp availability in 2026.
No. As of early 2026, Ibrexafungerp is not listed on the FDA Drug Shortage database. The medication is being manufactured and distributed by Scynexis.
However, "not in shortage" doesn't mean "easy to find." Many patients report difficulty locating Brexafemme at retail pharmacies. This is because of limited stocking — not a supply interruption.
Several factors contribute to the difficulty of finding Brexafemme at your local pharmacy:
For a deeper dive into these issues, read why Ibrexafungerp is so hard to find.
The cost of Brexafemme varies depending on your insurance coverage:
For detailed information on reducing your costs, check out how to save money on Ibrexafungerp.
Ibrexafungerp remains the only oral non-azole antifungal approved for vaginal yeast infections. However, the treatment landscape includes several well-established options:
Ibrexafungerp also has an IV formulation in late-stage clinical trials for invasive fungal infections, which could expand its use in hospital settings. However, for vaginal yeast infections, the oral tablet is the only approved form.
For a full comparison, see alternatives to Ibrexafungerp.
If you need Brexafemme, here are the best ways to locate it:
For step-by-step instructions, read our full guide on how to find Ibrexafungerp in stock near you.
While Ibrexafungerp (Brexafemme) is not in an official FDA shortage in 2026, it remains challenging to find at many retail pharmacies. The combination of single-source manufacturing, high cost, and low pharmacy demand creates a practical availability gap for patients.
If you've been prescribed Brexafemme, use tools like Medfinder to locate it, explore savings programs to manage cost, and work closely with your doctor to ensure you get the treatment you need — whether that's Brexafemme or an appropriate alternative.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.